Free
Case Reports  |   July 2002
Nerve Root Inflammation Demonstrated by Magnetic Resonance Imaging in a Patient with Transient Neurologic Symptoms after Intrathecal Injection of Lidocaine
Author Affiliations & Notes
  • Alexander Avidan, M.D.
    *
  • Moshe Gomori, M.D.
  • Elyad Davidson, M.D.
  • *Tutor in Anesthesiology, Hebrew University Hadassah Medical School, Staff Anesthesiologist, Department of Anesthesiology and Critical Care Medicine. †Professor in Radiology, Hebrew University Hadassah Medical School, Head MRI, Department of Radiology. ‡Lecturer in Anesthesiology, Hebrew University Hadassah Medical School, Staff Anesthesiologist, Department of Anesthesiology and Critical Care Medicine.
  • Received from the Department of Anesthesiology and Critical Care Medicine, Hebrew University Hadassah Medical School, Hadassah University Hospital, Jerusalem, Israel.
Article Information
Case Reports
Case Reports   |   July 2002
Nerve Root Inflammation Demonstrated by Magnetic Resonance Imaging in a Patient with Transient Neurologic Symptoms after Intrathecal Injection of Lidocaine
Anesthesiology 7 2002, Vol.97, 257-258. doi:
Anesthesiology 7 2002, Vol.97, 257-258. doi:
TRANSIENT neurologic symptoms after intrathecal injection of lidocaine are common. The main symptoms are severe pain and dysesthesia in the buttocks and legs after recovery from spinal anesthesia. The symptoms typically resolve within 1 week. No definitive etiology has been established until now. We report findings on magnetic resonance imaging (MRI) of a patient with transient neurologic symptoms after spinal anesthesia with lidocaine that indicated a local inflammatory process as the possible etiology for this symptom.
Case Report
A 60-yr-old healthy male patient (American Society of Anesthesiologists physical status class I) underwent excision of a perineal condylomata under spinal anesthesia. Anesthesia was performed with the patient in the sitting position with a 27-gauge pencil-point spinal needle (te me na SARL, Bondy, France) and 50 mg hyperbaric lidocaine (AstraZeneca, London, United Kingdom). Dural puncture was achieved in the first attempt, and no paresthesias were elicited. The hyperbaric lidocaine was diluted with cerebrospinal fluid. The patient remained seated for 5 min and then was placed in the prone jackknife position. Intraoperatively, the patient was hemodynamically stable, and the postoperative course was uneventful. The patient was released home pain-free within several hours following the procedure.
The next morning, the patient began to feel pain in his lower back radiating to his buttocks and legs. During the next few hours, the pain became severe, and the patient returned to the hospital.
On admission, the patient was in extreme discomfort and complained of intractable pain in his buttocks and thighs. There was no tenderness or signs of inflammation at the site of the spinal injection. Neurologic examination revealed no motor, sensory, or muscle–tendon reflex abnormalities. The patient denied having severe back pain or a similar episode in the past. Due to the severe pain and the radicular findings, we performed an MRI (with and without Gd-DTPA contrast material [Magnetol, Soreq, Israel]), which ruled out an epidural or spinal hematoma, direct nerve injury, or an infectious process. There were no signs of pressure to the cord or the spinal roots due to bulging discs or degenerative changes. The only abnormal finding was enhancement of the mildly thickened cauda equina and the lumbosacral nerve roots on the postcontrast study (post Gd-DTPA), which are consistent with nonspecific inflammatory or infiltrative processes (figs. 1 and 2).
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A  , before Gd-DTPA;B  , after Gd-DTPA).
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A 
	, before Gd-DTPA;B 
	, after Gd-DTPA).
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A  , before Gd-DTPA;B  , after Gd-DTPA).
×
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A  , before Gd-DTPA;B  , after Gd-DTPA).
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A 
	, before Gd-DTPA;B 
	, after Gd-DTPA).
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A  , before Gd-DTPA;B  , after Gd-DTPA).
×
Due to the severe pain, the patient was treated with intravenous morphine (patient-controlled analgesia), and the pain decreased gradually within several hours. The patient was released the next day with mild pain, which fully resolved the following day.
Discussion
The use of intrathecal lidocaine came under scrutiny in the past decade after an increasing number of reports of severe neurologic symptoms (transient neurologic symptoms, cauda equina syndrome) after spinal anesthesia with lidocaine. 1 There is a lower incidence of these symptoms when other local anesthetics are used for spinal anesthesia. 2–4 This supports the hypothesis that lidocaine has a neurotoxic effect, although other mechanisms, such as local anesthetics maldistribution, myofascial pain, and surgical positioning, have been proposed. 5–9 The mechanism of this postulated lidocaine toxicity is unknown. An ischemic effect of lidocaine on the spinal cord was ruled out. 10 The result of the MRI in this case showing enhancement of the cauda equina and the lumbosacral nerve roots may support the theory of a direct toxic effect of lidocaine. The MRI findings are suggestive of pial hyperemia or breakdown of the nerve root–blood barrier by a noninfectious inflammatory process. A similar picture can be found in patients with Guillain-Barré and Krabbe (demyelinating disorder) syndromes. 11–13 In Guillain-Barré syndrome, the degree of enhancement correlates well with the severity of the disease. 14 
The enhancement of the cauda equine roots indicates breakdown of the blood–nerve barrier. In the present case, it suggests a chemical irritation due to intrathecal anesthetic. This breakdown may be the cause of the neurologic deficit or just another effect of the intrathecal anesthetic. Until now, no studies were performed to investigate findings in MRI in patients after spinal anesthesia with and without neurologic symptoms. It is therefore impossible to conclude definitely from this case that the findings in the MRI prove direct toxic effect of lidocaine. However, in regard to similar MRI findings in other neurologic disorders, it is suggestive that toxic effects of lidocaine are the cause of the transient neurologic syndrome.
References
Gaiser RR: Should intrathecal lidocaine be used in the 21st century? J Clin Anesth 2000; 12: 476–81Gaiser, RR
Salmela L, Aromaa U: Transient radicular irritation after spinal anesthesia induced with hyperbaric solutions of cerebrospinal fluid-diluted lidocaine 50 mg/ml or mepivacaine 40 mg/ml or bupivacaine 5 mg/ml. Acta Anaesthesiol Scand 1998; 42: 765–9Salmela, L Aromaa, U
De Weert K, Traksel M, Gielen M, Slappendel R, Weber E, Dirksen R: The incidence of transient neurological symptoms after spinal anaesthesia with lidocaine compared to prilocaine. Anaesthesia 2000; 55: 1020–4De Weert, K Traksel, M Gielen, M Slappendel, R Weber, E Dirksen, R
Liguori GA, Zayas VM, Chisholm MF: Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. A nesthesiology 1998; 88: 619–23Liguori, GA Zayas, VM Chisholm, MF
Johnson ME: Potential neurotoxicity of spinal anesthesia with lidocaine. Mayo Clin Proc 2000; 75: 921–32Johnson, ME
Hiller A, Karjalainen K, Balk M, Rosenberg PH: Transient neurological symptoms after spinal anaesthesia with hyperbaric 5% lidocaine or general anaesthesia. Br J Anaesth 1999; 82: 575–9Hiller, A Karjalainen, K Balk, M Rosenberg, PH
Morisaki H, Masuda J, Kaneko S, Matsushima M, Takeda J: Transient neurologic syndrome in one thousand forty-five patients after 3% lidocaine spinal anesthesia. Anesth Analg 1998; 86: 1023–6Morisaki, H Masuda, J Kaneko, S Matsushima, M Takeda, J
Freedman JM, Li DK, Drasner K, Jaskela MC, Larsen B, Wi S: Transient neurologic symptoms after spinal anesthesia: An epidemiologic study of 1,863 patients [erratum appears in A nesthesiology 1998; 89:1614]. A nesthesiology 1998; 89: 633–41Freedman, JM Li, DK Drasner, K Jaskela, MC Larsen, B Wi, S
Pollock JE, Neal JM, Stephenson CA, Wiley CE: Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. A nesthesiology 1996; 84: 1361–7Pollock, JE Neal, JM Stephenson, CA Wiley, CE
Benveniste H, Qui H, Hedlund LW, Huttemeier PC, Steele SM, Johnson GA: In vivo diffusion-weighted magnetic resonance microscopy of rat spinal cord: Effect of ischemia and intrathecal hyperbaric 5% lidocaine. Reg Anesth Pain Med 1999; 24: 311–8Benveniste, H Qui, H Hedlund, LW Huttemeier, PC Steele, SM Johnson, GA
Patel H, Garg BP, Edwards MK: MRI of Guillain-Barre syndrome. J Comput Assist Tomogr 1993; 17: 651–2Patel, H Garg, BP Edwards, MK
Iwata F, Utsumi Y: MR imaging in Guillain-Barre syndrome. Pediatr Radiol 1997; 27: 36–8Iwata, F Utsumi, Y
Vasconcellos E, Smith M: MRI nerve root enhancement in Krabbe disease. Pediatr Neurol 1998; 19: 151–2Vasconcellos, E Smith, M
Gorson KC, Ropper AH, Muriello MA, Blair R: Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barre syndrome. Neurology 1996; 47: 813–7Gorson, KC Ropper, AH Muriello, MA Blair, R
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A  , before Gd-DTPA;B  , after Gd-DTPA).
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A 
	, before Gd-DTPA;B 
	, after Gd-DTPA).
Fig. 1. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine and spinal roots in the sagittal plane T9 sacrum (A  , before Gd-DTPA;B  , after Gd-DTPA).
×
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A  , before Gd-DTPA;B  , after Gd-DTPA).
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A 
	, before Gd-DTPA;B 
	, after Gd-DTPA).
Fig. 2. Enhancement on the post–Gd-DTPA study of the mildly swollen cauda equine at level of L3 (A  , before Gd-DTPA;B  , after Gd-DTPA).
×